Citations (75)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Tahirah Khaliq, Sadaqat Farooq, Malik A. Waseem, Phalisteen Sultan, Sabiyah Akhter & Qazi Parvaiz Hassan. (2023) Isolation of bioactive natural products from Rumex dentatus and their antimicrobial evaluation: A comparative study against various pathogenic bacteria. Analytical Chemistry Letters 13:3, pages 226-233.
Read now
Read now
Niels Kjær, Malene Plejdrup Hansen, Henrik Schou Pedersen, Morten Bondo Christensen & Linda Huibers. (2023) Development over time in point-of-care test use in Danish daytime and out-of-hours general practice: a register-based study. Scandinavian Journal of Primary Health Care 41:2, pages 108-115.
Read now
Read now
Arianna Pompilio & Giovanni Di Bonaventura. (2020) Ambient air pollution and respiratory bacterial infections, a troubling association: epidemiology, underlying mechanisms, and future challenges. Critical Reviews in Microbiology 46:5, pages 600-630.
Read now
Read now
Victoria Divino, Jennifer Schranz, Maureen Early, Hemal Shah, Miao Jiang & Mitch DeKoven. (2020) The annual economic burden among patients hospitalized for community-acquired pneumonia (CAP): a retrospective US cohort study. Current Medical Research and Opinion 36:1, pages 151-160.
Read now
Read now
Articles from other publishers (71)
Zhenyu Wang, Fanglong Li, Er-bu Aga, Xiaoxia Liang, Changliang He, Lizi Yin, Funeng Xu, Haohuan Li, Huaqiao Tang & Cheng Lv. (2024) ‘Pterocephalodes hookeri-Onosma hookeri’ decoction protects against LPS-induced pulmonary inflammation via inhibiting TLR4/ NF-κB signaling pathway. Journal of Ethnopharmacology 318, pages 116918.
Crossref
Crossref
Nurul Izzaty Najwa Zahari, Engku Nur Syafirah Engku Abd Rahman, Ahmad Adebayo Irekeola, Naveed Ahmed, Ali A. Rabaan, Jawaher Alotaibi, Shayea A. Alqahtani, Mohammed Y. Halawi, Ibrahim Ateeq Alamri, Mohammed S. Almogbel, Amal H. Alfaraj, Fatimah Al Ibrahim, Manar Almaghaslah, Mohammed Alissa & Chan Yean Yean. (2023) A Review of the Resistance Mechanisms for β-Lactams, Macrolides and Fluoroquinolones among Streptococcus pneumoniae. Medicina 59:11, pages 1927.
Crossref
Crossref
Nurgul Ablakimova, Gaziza A. Smagulova, Svetlana Rachina, Aigul Z. Mussina, Afshin Zare, Nadiar M. Mussin, Asset A. Kaliyev, Reza Shirazi, Nader Tanideh & Amin Tamadon. (2023) Bibliometric Analysis of Global Research Output on Antimicrobial Resistance among Pneumonia Pathogens (2013–2023). Antibiotics 12:9, pages 1411.
Crossref
Crossref
Thomas P. LodiseKyle GunterFan MuEmily GaoDanni YangErica YimSteve SandorGail Berman. (2023) Real-world effectiveness of omadacycline and impact of unapproved omadacycline prescription claims among adult outpatients with community-acquired bacterial pneumonia or acute bacterial skin and skin structure infections. Journal of Managed Care & Specialty Pharmacy 29:8, pages 952-964.
Crossref
Crossref
Ruifang Li, Pu Hao, Kedong Yin, Qingpeng Xu, Shiming Ren, Yingyuan Zhao, Lan Zhang & Beibei Zhang. (2023)
Activities of a broad‐spectrum antimicrobial peptide analogue SAMP‐A4‐C8 and its combat against pneumonia in
Staphylococcus aureus‐
infected mice
. Journal of Peptide Science.
Crossref
Crossref
Hirad Houshmand, Camilla Porta, Lorenzo Pradelli, Matteo Pinciroli & Giovanni Sotgiu. (2023) Cost-Impact Analysis of a Novel Diagnostic Test to Assess Community-Acquired Pneumonia Etiology in the Emergency Department Setting: A Multi-Country European Study. International Journal of Environmental Research and Public Health 20:5, pages 3853.
Crossref
Crossref
Nitish Rawat, Anjali, Shreyata, Benoy Sabu, Rohit Jamwal, Pukhrambam Pushpa Devi, Karuna Yadav, Harpreet Singh Raina & Raman Rajagopal. (2023) Understanding the role of insects in the acquisition and transmission of antibiotic resistance. Science of The Total Environment 858, pages 159805.
Crossref
Crossref
Luciano Zane, Stefanie Kraschowetz, Monalisa Martins Trentini, Vitor dos Santos Alves, Sergio Carneiro Araujo, Cibelly Goulart, Luciana Cezar de Cerqueira Leite & Viviane Maimoni Gonçalves. (2023) Peptide linker increased the stability of pneumococcal fusion protein vaccine candidate. Frontiers in Bioengineering and Biotechnology 11.
Crossref
Crossref
Anni K. Saralahti, Sanna-Kaisa E. Harjula, Tommi Rantapero, Meri I. E. Uusi-Mäkelä, Mikko Kaasinen, Maiju Junno, Hannaleena Piippo, Matti Nykter, Olli Lohi, Samuli Rounioja, Mataleena Parikka & Mika Rämet. (2023) Characterization of the innate immune response to Streptococcus pneumoniae infection in zebrafish. PLOS Genetics 19:1, pages e1010586.
Crossref
Crossref
Kamaleldin B. Said, Naif Saad Alghasab, Mohammed S. M. Alharbi, Ahmed Alsolami, Mohd Saleem, Sulaf A. Alhallabi, Shahad F. Alafnan, Azharuddin Sajid Syed Khaja & Taha E. Taha. (2023) Molecular and Source-Specific Profiling of Hospital Staphylococcus aureus Reveal Dominance of Skin Infection and Age-Specific Selections in Pediatrics and Geriatrics. Microorganisms 11:1, pages 149.
Crossref
Crossref
Jie Tang, Qiuhong Ouyang, Yanyan Li, Peisen Zhang, Weihua Jin, Shuang Qu, Fengmei Yang, Zhanlong He & Meng Qin. (2022) Nanomaterials for Delivering Antibiotics in the Therapy of Pneumonia. International Journal of Molecular Sciences 23:24, pages 15738.
Crossref
Crossref
Felipe Serra Campelo, Rossana de Aguiar Cordeiro & Fernanda Edna Araújo Moura. (2022) The role of human bocavirus as an agent of community-acquired pneumonia in children under 5 years of age in Fortaleza, Ceará (Northeast Brazil). Brazilian Journal of Microbiology 53:4, pages 1915-1924.
Crossref
Crossref
Ru Xiao, Yadong Liu, Yuting Li, Yaoyan Shen, Shuwen Zhou, Pengfei Cui, Huaanzi Hu, Pengju Jiang, Lin Qiu, Cheng Wang & Jianhao Wang. (2022) Polymerized Tannic Acid Offers a Nanosized Platform to Combat Bacterial Infection. ACS Biomaterials Science & Engineering 8:11, pages 5008-5017.
Crossref
Crossref
Daniel M. Musher, Ronald Anderson & Charles Feldman. (2022) The remarkable history of pneumococcal vaccination: an ongoing challenge. Pneumonia 14:1.
Crossref
Crossref
Joshua C. Nwabuife, Calvin A. Omolo & Thirumala Govender. (2022) Nano delivery systems to the rescue of ciprofloxacin against resistant bacteria “E. coli; P. aeruginosa; Saureus; and MRSA” and their infections. Journal of Controlled Release 349, pages 338-353.
Crossref
Crossref
Chung-Jong Kim, Kyoung-Ho Song, Nam-Kyong Choi, Jeonghoon Ahn, Ji Yun Bae, Hee Jung Choi, Younghee Jung, Seung Soon Lee, Ji-Hwan Bang, Eu Suk Kim, Song Mi Moon, Je Eun Song, Yee Gyung Kwak, Shin Hye Chun, Yeon-Sook Kim, Kyung-Hwa Park, Yu Min Kang, Pyoeng Gyun Choe, Shinwon Lee, Hong Bin Kim, Sang Won Park, Chan Mi Lee, Sook-In Jung, Seong Eun Kim, Wan Beom Park, Nam Joong Kim, Sun Hee Lee, Hyunju Lee, Jeong Su Park & Young-Jun Kim. (2022) Socioeconomic burden of pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa in Korea. Scientific Reports 12:1.
Crossref
Crossref
Clement Yaw Effah, Ruoqi Miao, Emmanuel Kwateng Drokow, Clement Agboyibor, Ruiping Qiao, Yongjun Wu, Lijun Miao & Yanbin Wang. (2022) Machine learning-assisted prediction of pneumonia based on non-invasive measures. Frontiers in Public Health 10.
Crossref
Crossref
Shubham Adhikary, Meher Kaur Duggal, Saraswathy Nagendran, Meena Chintamaneni, Hardeep Singh Tuli & Ginpreet Kaur. (2022) Lefamulin: a New Hope in the Field of Community-Acquired Bacterial Pneumonia. Current Pharmacology Reports 8:6, pages 418-426.
Crossref
Crossref
Chokkalingam Mohanasundari, Sorimuthu Anbalagan, Kesavan Srinivasan, Mathiyazhagan Narayanan, Mythili Saravanan, Sulaiman Ali Alharbi, Saleh H. Salmen, Tran Cam Nhung & Arivalagan Pugazhendhi. (2022) Antibacterial activity potential of leaf extracts of Blepharis maderaspatensis and Ziziphus oenoplia against antibiotics resistant Pseudomonas strains isolated from pus specimens. Process Biochemistry 118, pages 24-31.
Crossref
Crossref
Susanne Paukner, Lisa Goldberg, Elizabeth Alexander, Anita F. Das, Stefanie Heinrich, Pritty Patel, Gregory J. Moran, Christian Sandrock, Thomas M. FileJrJr, Jorge E. Vidal, Ken B. Waites, Steven P. Gelone & Jennifer Schranz. (2022) Pooled microbiological findings and efficacy outcomes by pathogen in adults with community-acquired bacterial pneumonia from the Lefamulin Evaluation Against Pneumonia (LEAP) 1 and LEAP 2 phase 3 trials of lefamulin versus moxifloxacin. Journal of Global Antimicrobial Resistance 29, pages 434-443.
Crossref
Crossref
Amal Al Ghassani & Mohammad Rababa. (2021) Size of Core Network: Why Less May Be More for Older Adults with Dementia. Ageing International 47:2, pages 169-179.
Crossref
Crossref
Emilia Cercenado, Cristina Loras, Alejandro Cobos & Juan Carlos Sanz. (2022) In vitro activity of delafloxacin against highly levofloxacin-resistant invasive isolates of Streptococcus pneumoniae. Enfermedades infecciosas y microbiologia clinica (English ed.) 40:3, pages 131-133.
Crossref
Crossref
Emilia Cercenado, Cristina Loras, Alejandro Cobos & Juan Carlos Sanz. (2022) In vitro activity of delafloxacin against highly levofloxacin-resistant invasive isolates of Streptococcus pneumoniae. Enfermedades Infecciosas y Microbiología Clínica 40:3, pages 131-133.
Crossref
Crossref
Nur Farisya Shamsudin, Qamar Uddin Ahmed, Syed Mahmood, Syed Adnan Ali Shah, Alfi Khatib, Sayeed Mukhtar, Meshari A. Alsharif, Humaira Parveen & Zainul Amiruddin Zakaria. (2022) Antibacterial Effects of Flavonoids and Their Structure-Activity Relationship Study: A Comparative Interpretation. Molecules 27:4, pages 1149.
Crossref
Crossref
Muluneh Assefa, Abiye Tigabu, Teshome Belachew & Belay Tessema. (2022) Bacterial profile, antimicrobial susceptibility patterns, and associated factors of community-acquired pneumonia among adult patients in Gondar, Northwest Ethiopia: A cross-sectional study. PLOS ONE 17:2, pages e0262956.
Crossref
Crossref
Aleksandra A. TaubeT.V. AlexandrovaO.A. DemidovaM.V. ZhuravlevaE.A. StepanovR.N. Alyautdin. (2022) Analysis of antibiotic prescriptions in patients with community-acquired pneumonia in clinical practice. Clinical Microbiology and Antimicrobial Chemotherapy 24:4, pages 388-394.
Crossref
Crossref
Richard F. Van Besien, Nicholas Hampton, Scott T. Micek & Marin H. Kollef. (2022) Ceftriaxone resistance and adequacy of initial antibiotic therapy in community onset bacterial pneumonia. Medicine 101:20, pages e29159.
Crossref
Crossref
Erin B. Brazel, Aimee Tan, Stephanie L. Neville, Amy R. Iverson, Saumya R. Udagedara, Bliss A. Cunningham, Mwilye Sikanyika, David M.P. De Oliveira, Bernhard Keller, Lisa Bohlmann, Ibrahim M. El-Deeb, Katherine Ganio, Bart A. Eijkelkamp, Alastair G. McEwan, Mark von Itzstein, Megan J. Maher, Mark J. Walker, Jason W. Rosch & Christopher A. McDevitt. (2022) Dysregulation of Streptococcus pneumoniae zinc homeostasis breaks ampicillin resistance in a pneumonia infection model. Cell Reports 38:2, pages 110202.
Crossref
Crossref
Susanne Paukner, David Mariano, Anita F. Das, Gregory J. Moran, Christian Sandrock, Ken B. Waites & Thomas M. FileJr.Jr.. (2021) Lefamulin in Patients with Community-Acquired Bacterial Pneumonia Caused by Atypical Respiratory Pathogens: Pooled Results from Two Phase 3 Trials. Antibiotics 10:12, pages 1489.
Crossref
Crossref
Claire Dupuis, Ayman Sabra, Juliette Patrier, Gwendoline Chaize, Amine Saighi, Céline Féger, Alexandre Vainchtock, Jacques Gaillat & Jean-François Timsit. (2021) Burden of pneumococcal pneumonia requiring ICU admission in France: 1-year prognosis, resources use, and costs. Critical Care 25:1.
Crossref
Crossref
Thomas M. FileJr.Jr., Elizabeth Alexander, Lisa Goldberg, Anita F. Das, Christian Sandrock, Susanne Paukner & Gregory J. Moran. (2021) Lefamulin efficacy and safety in a pooled phase 3 clinical trial population with community-acquired bacterial pneumonia and common clinical comorbidities. BMC Pulmonary Medicine 21:1.
Crossref
Crossref
Tarek Al-Sanouri, Sabah Mahdi, Ilham Abu Khader, Asaad Mahdi, Alp Dogu, Amine Amiche, Sereen Iweir, Mudhafar Qader, Adel Belbaisi & Riyad AlHilfi. (2021) The epidemiology of meningococcal meningitis: multicenter, hospital-based surveillance of meningococcal meningitis in Iraq. IJID Regions 1, pages 100-106.
Crossref
Crossref
Joshua C. Nwabuife, Amit Madhaorao Pant & Thirumala Govender. (2021) Liposomal delivery systems and their applications against Staphylococcus aureus and Methicillin-resistant Staphylococcus aureus. Advanced Drug Delivery Reviews 178, pages 113861.
Crossref
Crossref
E. A. Sokova, V. V. Arkhipov, O. A. Demidova, I. A. Mazerkina, T. V. Alexandrova & M. V. Zhuravleva. (2021) Risk Factors and Characteristics of Adverse Reactions Associated with the Use of Beta-Lactam Antibiotics in Older Patients. Safety and Risk of Pharmacotherapy 9:3, pages 128-135.
Crossref
Crossref
Evdoxia Kyriazopoulou, Athanasios Karageorgos, Lydia Liaskou-Antoniou, Panagiotis Koufargyris, Asimina Safarika, Georgia Damoraki, Vasileios Lekakis, Maria Saridaki, George Adamis & Evangelos J. Giamarellos-Bourboulis. (2021) BioFire® FilmArray® Pneumonia Panel for Severe Lower Respiratory Tract Infections: Subgroup Analysis of a Randomized Clinical Trial. Infectious Diseases and Therapy 10:3, pages 1437-1449.
Crossref
Crossref
Sanhu Gou, Beibei Li, Xu Ouyang, Zufang Ba, Chao Zhong, Tianyue Zhang, LinLin Chang, Yuewen Zhu, Jingying Zhang, Ningyi Zhu, Yun Zhang, Hui Liu & Jingman Ni. (2021) Novel Broad-Spectrum Antimicrobial Peptide Derived from Anoplin and Its Activity on Bacterial Pneumonia in Mice. Journal of Medicinal Chemistry 64:15, pages 11247-11266.
Crossref
Crossref
Vuk Uskoković. (2021) Health economics matters in the nanomaterial world: Cost-effectiveness of utilizing an inhalable antibacterial nanomaterial for the treatment of multidrug-resistant pneumonia. Technology in Society 66, pages 101641.
Crossref
Crossref
Richard Moore, Bethany A. Wattengel, Michael T. Carter, Alan J. Lesse, John A. Sellick & Kari A. Mergenhagen. (2021) Sputum susceptibilities in a nationwide veteran cohort. American Journal of Infection Control 49:8, pages 995-999.
Crossref
Crossref
Robert M Taylor, James A Karlowsky, Melanie R Baxter, Heather J Adam, Andrew Walkty, Philippe Lagacé-Wiens & George G Zhanel. (2021) In vitro susceptibility of common bacterial pathogens causing respiratory tract infections in Canada to lefamulin, a new pleuromutilin. Official Journal of the Association of Medical Microbiology and Infectious Disease Canada 6:2, pages 149-162.
Crossref
Crossref
Charles S. Dela Cruz, Scott E. Evans, Marcos I. Restrepo, Nathan Dean, Antonio Torres, Isabel Amara-Elori, Shanjana Awasthi, Elisabet Caler, Bin Cao, James D. Chalmers, Jean Chastre, Taylor S. Cohen, Alan H. Cohen, Kristina Crothers, Y. Peter Di, Marie E. Egan, Charles Feldman, Samir Gautam, E. Scott Halstead, Susanne Herold, Barbara E. Jones, Carlos Luna, Michael S. Niederman, Raul Mendez, Rosario Menendez, Joseph P. Mizgerd, Roomi Nusrat, Julio Ramirez, Yuichiro Shindo, Grant Waterer, Samantha M. Yeligar & Richard G. Wunderink. (2021) Understanding the Host in the Management of Pneumonia. An Official American Thoracic Society Workshop Report. Annals of the American Thoracic Society 18:7, pages 1087-1097.
Crossref
Crossref
Pengxiang Zhou, Xiaoling Wang, Xianglin Zhang, Baoping Xu, Xiaomei Tong, Wei Zhou, Kunling Shen & Suodi Zhai. (2021) Recommendations on off‐label use of intravenous azithromycin in children. International Journal of Clinical Practice 75:7.
Crossref
Crossref
Balaji Veeraraghavan, Rosemol Varghese, Karnika Saigal, S Balasubramanian, P Sulochana Putli Bai, Binesh Lal Y, Ayyanraj Neeravi, Pavithra Baskar, Kavipriya Anandhan, C P Girish Kumar, Yuvraj Jayaraman, Vijaya Lakshmi Nag, Sujata Baveja, Bhavana J, Shrikrishna A Joshi & Ranganathan Iyer. (2021) Activity of novel lactone ketolide nafithromycin against multicentric invasive and non-invasive pneumococcal isolates collected in India. JAC-Antimicrobial Resistance 3:2.
Crossref
Crossref
Antoni Torres, Lynne Garrity-Ryan, Courtney Kirsch, Judith N. Steenbergen, Paul B. Eckburg, Anita F. Das, Marla Curran, Amy Manley, Evan Tzanis & Paul C. McGovern. (2021) Omadacycline vs moxifloxacin in adults with community-acquired bacterial pneumonia. International Journal of Infectious Diseases 104, pages 501-509.
Crossref
Crossref
Takahiro Sawada, Masayuki Katayama, Shogo Takatani & Yoshiyuki Ohiro. (2021) Early detection of drug-resistant Streptococcus pneumoniae and Haemophilus influenzae by quantitative flow cytometry. Scientific Reports 11:1.
Crossref
Crossref
F Cools, P Delputte & P Cos. (2021)
The search for novel treatment strategies for
Streptococcus pneumoniae
infections
. FEMS Microbiology Reviews.
Crossref
Crossref
Syeda Sahra, Abdullah Jahangir, Rachelle Hamadi, Ahmad Jahangir & Allison Glaser. (2021) Clinical and Microbiologic Efficacy and Safety of Imipenem/Cilastatin/Relebactam in Complicated Infections: A Meta-analysis. Infection & Chemotherapy 53:2, pages 271.
Crossref
Crossref
Klepikov I. (2020) Lessons not learned in Antibiotic Therapy. Journal of Health Care and Research 1:3, pages 209-214.
Crossref
Crossref
Shao-Huan Lan, Chih-Cheng Lai, Shen-Peng Chang, Li-Chin Lu, Shun-Hsing Hung & Wei-Ting Lin. (2020) Five-day antibiotic treatment for community-acquired bacterial pneumonia: A systematic review and meta-analysis of randomized controlled trials. Journal of Global Antimicrobial Resistance 23, pages 94-99.
Crossref
Crossref
Ian E. Cock & Sandy F. Van Vuuren. (2020) The traditional use of southern African medicinal plants for the treatment of bacterial respiratory diseases: A review of the ethnobotany and scientific evaluations. Journal of Ethnopharmacology 263, pages 113204.
Crossref
Crossref
Igor Klepikov. (2020) COVID-19. WHO CAN HELP US?. International Journal of Research -GRANTHAALAYAH 8:10, pages 298-303.
Crossref
Crossref
I. Klepikov. (2020) COVID-19: Success Depends on Medical Concepts, Not Political Views. International Journal of Coronaviruses 2:1, pages 21-25.
Crossref
Crossref
Charles Feldman & Ronald Anderson. (2020) Platelets and Their Role in the Pathogenesis of Cardiovascular Events in Patients With Community-Acquired Pneumonia. Frontiers in Immunology 11.
Crossref
Crossref
Hung-Jen Tang, Jui-Hsiang WangChih-Cheng Lai. (2020) Lefamulin vs moxifloxacin for community-acquired bacterial pneumonia. Medicine 99:29, pages e21223.
Crossref
Crossref
Freya Cools, Dhoha Triki, Nele Geerts, Peter Delputte, Denis Fourches & Paul Cos. (2020) In vitro and in vivo Evaluation of in silico Predicted Pneumococcal UDPG:PP Inhibitors. Frontiers in Microbiology 11.
Crossref
Crossref
Igor Klepikov. (2020) Acute Lung Inflammation: Old Illusions of the New Version. International Journal of Research Studies in Medical and Health Sciences 5:7, pages 1-5.
Crossref
Crossref
Ke Bai, Wenjun Liu, Chengjun Liu, Yueqiang Fu, Jun Hu, Yanran Qin, Qiaoying Zhang, Hongyan Chen, Feng Xu & Changda Li. (2020) Clinical Analysis of 25 COVID-19 Infections in Children. Pediatric Infectious Disease Journal 39:7, pages e100-e103.
Crossref
Crossref
Igor Klepikov. (2020) Acute Pneumonia and COVID-19: Problems of Today. International Journal of Coronaviruses 1:1, pages 16-18.
Crossref
Crossref
Scott T. Micek, James Simmons, Nicholas Hampton & Marin H. Kollef. (2020) Characteristics and outcomes among a hospitalized patient cohort with Streptococcus pneumoniae infection. Medicine 99:18, pages e20145.
Crossref
Crossref
D Torumkuney, E Bratus, O Yuvko, T Pertseva & I Morrissey. (2020) Results from the Survey of Antibiotic Resistance (SOAR) 2016–17 in Ukraine: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints. Journal of Antimicrobial Chemotherapy 75:Supplement_1, pages i100-i111.
Crossref
Crossref
D Torumkuney, A Tunger, B Sancak, A Bıçakçıgil, B Altun, Z Aktas, C Kayacan & I Morrissey. (2020) Results from the Survey of Antibiotic Resistance (SOAR) 2015–17 in Turkey: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints. Journal of Antimicrobial Chemotherapy 75:Supplement_1, pages i88-i99.
Crossref
Crossref
D Torumkuney, S Anwar, S Nizamuddin, N Malik & I Morrissey. (2020) Results from the Survey of Antibiotic Resistance (SOAR) 2015–17 in Pakistan: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints. Journal of Antimicrobial Chemotherapy 75:Supplement_1, pages i76-i87.
Crossref
Crossref
D Torumkuney, E Mokaddas, A Jiman-Fatani, A Ageel, Z Daoud, Y Bouferraa, M B Zerdan & I Morrissey. (2020) Results from the Survey of Antibiotic Resistance (SOAR) 2015–17 in the Middle East (Kuwait, Lebanon and Saudi Arabia): data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints. Journal of Antimicrobial Chemotherapy 75:Supplement_1, pages i60-i75.
Crossref
Crossref
D Torumkuney, J Smayevsky, M S Relloso, A Sucari, M Pennini, E Brilla, V Vilches, Y De la Cruz & I Morrissey. (2020) Results from the Survey of Antibiotic Resistance (SOAR) 2015–17 in Latin America (Argentina, Chile and Costa Rica): data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints. Journal of Antimicrobial Chemotherapy 75:Supplement_1, pages i43-i59.
Crossref
Crossref
D Torumkuney, A Hammami, S Mezghani Maalej, N Ben Ayed, G Revathi, K Zerouali, N Elmdaghri, A K Gachii & I Morrissey. (2020) Results from the Survey of Antibiotic Resistance (SOAR) 2015–18 in Tunisia, Kenya and Morocco: data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints. Journal of Antimicrobial Chemotherapy 75:Supplement_1, pages i2-i18.
Crossref
Crossref
Claudia Hirschfeld, Alejandro Gómez-Mejia, Jürgen Bartel, Christian Hentschker, Manfred Rohde, Sandra Maaß, Sven Hammerschmidt & Dörte Becher. (2020) Proteomic Investigation Uncovers Potential Targets and Target Sites of Pneumococcal Serine-Threonine Kinase StkP and Phosphatase PhpP. Frontiers in Microbiology 10.
Crossref
Crossref
Victoria Divino, Jennifer Schranz, Maureen Early, Hemal Shah, Miao Jiang & Mitch DeKoven. (2020) The 1-year economic burden of community-acquired pneumonia (CAP) initially managed in the outpatient setting in the USA. Journal of Comparative Effectiveness Research 9:2, pages 127-140.
Crossref
Crossref
Jeffery Ho & Margaret Ip. (2019) Antibiotic-Resistant Community-Acquired Bacterial Pneumonia. Infectious Disease Clinics of North America 33:4, pages 1087-1103.
Crossref
Crossref
Kgashane Matapa, Therese Dix-Peek, Riana Cockeran, Ronald Anderson, Helen Steel & Charles Feldman. (2019) Cigarette smoke exposure induces expression of the
pneumococcal <i>erm</i>(B) macrolide resistance gene. Tobacco Induced Diseases 17:November.
Crossref
Crossref
Elizabeth Alexander, Lisa Goldberg, Anita F. Das, Gregory J. Moran, Christian Sandrock, Leanne B. Gasink, Patricia Spera, Carolyn Sweeney, Susanne Paukner, Wolfgang W. Wicha, Steven P. Gelone & Jennifer Schranz. (2019) Oral Lefamulin vs Moxifloxacin for Early Clinical Response Among Adults With Community-Acquired Bacterial Pneumonia. JAMA 322:17, pages 1661.
Crossref
Crossref
Shao-Huan Lan, Shen-Peng Chang, Chih-Cheng Lai, Li-Chin Lu & Chien-Ming Chao. (2019) Efficacy and Safety of Ceftaroline for the Treatment of Community-Acquired Pneumonia: A Systemic Review and Meta-Analysis of Randomized Controlled Trials. Journal of Clinical Medicine 8:6, pages 824.
Crossref
Crossref
Susanne Paukner, Steven P. Gelone, S. J. Ryan Arends, Robert K. Flamm & Helio S. Sader. (2019) Antibacterial Activity of Lefamulin against Pathogens Most Commonly Causing Community-Acquired Bacterial Pneumonia: SENTRY Antimicrobial Surveillance Program (2015–2016). Antimicrobial Agents and Chemotherapy 63:4.
Crossref
Crossref